Download PDF
Thromb Haemost 1959; 03(02): 187-193
DOI: 10.1055/s-0038-1654381
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Acquired Hemorrhagic Diathesis of Unknown Nature

C. F Borchgrevink
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
,
A Hellem
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
,
D Voss
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
,
B. A Waaler
1   Institute for Thrombosis Research, University Hospital, Rikshospitalet, Oslo, Norway (Head: Prof. P. A. Owren)
› Author Affiliations
Further Information

Publication History

Publication Date:
08 June 2018 (online)

   Permissions and Reprints

Summary

1) A case of a severe, acquired hemorrhagic diathesis, complicating a carcinoma of the stomach, is reported.

2) The only pathological hemostatic finding was a markedly prolonged bleeding time.

3) Platelets were normal; the capillaries seemed to be normal. There was no increased fibrinolysis, and no other defect in his clotting mechanism could be discovered.

4) The prolonged bleeding time was probably caused by a hitherto undescribed mechanism.

 

  • References

  • 1 Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path 1953; 6: 23
    CrossrefPubMedGoogle Scholar
  • 2 Borchgrevink C. F, Waaler B. A. The secondary bleeding time. A new method for the differentiation of hemorrhagic disorders. Acta med. scand 1958; 162: 361
    PubMedGoogle Scholar
  • 3 Hellem A. Demonstration of a factor in blood influencing the adhesivity of platelets to foreign surfaces. Paper no. 313, 7th Congr Int. Soc. Haemat; Rome: 1958
    Google Scholar
  • 4 Hjort P, Rapaport S. I, Owren P. A. A simple, specific one-stage prothrombin assay using Russell’s viper venom in cephalin suspension. J. Lab. clin. Med 1955; 46: 89
    PubMedGoogle Scholar
  • 5 Hjort P, Stormorken H. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate. Scand. J. clin. Lab. Invest 1957; 9 29 Suppl 86
    PubMedGoogle Scholar
  • 6 Nygaard K. K. A direct method of counting platelets in oxalated plasma. Proc. Mayo Clin 1933; 8: 365
    PubMedGoogle Scholar
  • 7 Nilsson I. M, Blombäck M, Francken I. von: On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand 1957; 159: 35
    PubMedGoogle Scholar
  • 8 Nilsson I. M, Blombäck M, Jorpes E, Blombäck B, Johansson S. v Willebrand’s disease and its correction with human plasma fraction 1–0. Acta med. scand 1957; 159: 179
    PubMedGoogle Scholar
  • 9 Owren P. A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest 1951; 3: 201
    CrossrefPubMedGoogle Scholar
  • 10 Stapp W. F. A one-stage method for the assay of antihemophilic factor B (AHF B). With a comment on the antihemophilic factor B (AHF B) concentration in phenyl-indanedione (PID) therapy. Scand. J. clin. Lab. Invest 1958; 10: 169
    CrossrefPubMedGoogle Scholar
  • 11 Stefanini M, Dameshek W. The hemorrhagic disorders. Grune & Stratton; New York: 1955: 368
    Google Scholar
  • 12 Voss D. Untersuchungen zur Gerinnsel-retraction. Paper no. 346, 7th Congr Int. Soc. Haemat; Rome: 1958
    Google Scholar
  • 13 Waaler B. A. Simultaneous contribution to the formation of thrombin by the intrinsic and extrinsic blood clotting systems. Scand. J. clin. Lab. Invest 1957; 9: 322
    CrossrefPubMedGoogle Scholar
  • 14 Waaler B. A. Contact activation of blood. Studies on a plasma factor formed on contact with glass and similar surfaces, and related to the intrinsic blood clotting system Oslo University Press; Oslo: 1959: 133
    Google Scholar
  • 15 Waaler B. A. Assay of antihemophilic factor A (AHF A)(In press)
    PubMed